Difference between revisions of "Timeline of Schistosomiasis Control Initiative"

From Timelines
Jump to: navigation, search
(Full timeline)
 
(29 intermediate revisions by 2 users not shown)
Line 14: Line 14:
 
| 2013 || SCI announces that it has facilitated delivery of its 100 millionth treatment of {{w|praziquantel}} against schistosomiasis thanks to funding from private donations.<ref name="SCIvv"/>
 
| 2013 || SCI announces that it has facilitated delivery of its 100 millionth treatment of {{w|praziquantel}} against schistosomiasis thanks to funding from private donations.<ref name="SCIvv"/>
 
|-
 
|-
| 2016 || SCI reaches an annual delivery of over 50 million treatments for schistosomiasis and {{w|soil-transmitted helminths}}.
+
| 2016 || SCI reaches an annual delivery of over 50 million treatments for schistosomiasis and {{w|soil-transmitted helminths}}.<ref name="SCIvv"/>
 
|-
 
|-
| 2018 || SCI facilitates the delivery of its 200 millionth treatment against parasitic worm infections.
+
| 2018 || SCI facilitates the delivery of its 200 millionth treatment against parasitic worm infections.<ref name="SCIvv"/>
 
|-
 
|-
 
|}
 
|}
Line 38: Line 38:
 
|-
 
|-
 
| 2007 || || Expansion || SCI program starts in Burundi.<ref name="OUR REACH">{{cite web |title=OUR REACH |url=https://www.schistosomiasiscontrolinitiative.org/our-reach |website=schistosomiasiscontrolinitiative.org |accessdate=12 March 2019}}</ref> || {{w|Burundi}}
 
| 2007 || || Expansion || SCI program starts in Burundi.<ref name="OUR REACH">{{cite web |title=OUR REACH |url=https://www.schistosomiasiscontrolinitiative.org/our-reach |website=schistosomiasiscontrolinitiative.org |accessdate=12 March 2019}}</ref> || {{w|Burundi}}
 +
|-
 +
| 2008 || || Organization || The Schistosomiasis Consortium for Operational Research and Evaluation (SCORE) is established to answer strategic questions about schistosomiasis control.<ref>{{cite journal |last1=Ezeamama |first1=Amara E. |last2=He |first2=Chun-La |last3=Shen |first3=Ye |last4=Yin |first4=Xiao-Ping |last5=Binder |first5=Sue C. |last6=CampbellJr. |first6=Carl H. |last7=Rathbun |first7=Stephen |last8=Whalen |first8=Christopher C. |last9=N’Goran |first9=Eliézer K. |last10=Utzinger |first10=Jürg |last11=Olsen |first11=Annette |last12=Magnussen |first12=Pascal |last13=Kinung’hi |first13=Safari |last14=Fenwick |first14=Alan |last15=Phillips |first15=Anna |last16=Ferro |first16=Josefo |last17=Karanja |first17=Diana M. S. |last18=Mwinzi |first18=Pauline N. M. |last19=Montgomery |first19=Susan |last20=Secor |first20=W. Evan |last21=Hamidou |first21=Amina |last22=Garba |first22=Amadou |last23=King |first23=Charles H. |last24=Colley |first24=Daniel G. |title=Gaining and sustaining schistosomiasis control: study protocol and baseline data prior to different treatment strategies in five African countries |doi=10.1186/s12879-016-1575-2 |url=https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-016-1575-2}}</ref> ||
 +
|-
 +
| 2009 || || Review || GiveWell begins reviewing SCI.<ref name="Schistosomiasis Control Initiative - November 2011 Review"/> ||
 
|-
 
|-
 
| 2010 || || Expansion || SCI begins working in Côte d'Ivoire.<ref name="Schistosomiasis Control Initiative: Supplementary Information">{{cite web |title=Schistosomiasis Control Initiative: Supplementary Information |url=https://www.givewell.org/charities/schistosomiasis-control-initiative/supplementary-information |website=givewell.org |accessdate=11 March 2019}}</ref> || {{w|Côte d'Ivoire}}
 
| 2010 || || Expansion || SCI begins working in Côte d'Ivoire.<ref name="Schistosomiasis Control Initiative: Supplementary Information">{{cite web |title=Schistosomiasis Control Initiative: Supplementary Information |url=https://www.givewell.org/charities/schistosomiasis-control-initiative/supplementary-information |website=givewell.org |accessdate=11 March 2019}}</ref> || {{w|Côte d'Ivoire}}
|-
 
| 2010 || || Funding || SCI receives £10.5 million (plus separate funding for drugs) from the British {{w|Department for International Development}} for treating schistosomiasis and {{w|soil-transmitted helminthiasis}} in eight countries over five years.<ref name="Schistosomiasis Control Initiative: Supplementary Information"/> ||
 
 
|-
 
|-
 
| 2010 || October || Funding || SCI receives £10.5 million (plus separate funding for drugs) from the British {{w|Department for International Development}} for treating schistosomiasis and {{w|soil-transmitted helminthiasis}} in eight countries over five years.<ref>{{cite web |title=Imperial initiative to protect children from tropical disease awarded £25m government backing |url=http://www.imperial.ac.uk/news/93621/imperial-initiative-protect-children-from-tropical/ |website=imperial.ac.uk |accessdate=11 March 2019}}</ref><ref name="Schistosomiasis Control Initiative: Supplementary Information"/> ||
 
| 2010 || October || Funding || SCI receives £10.5 million (plus separate funding for drugs) from the British {{w|Department for International Development}} for treating schistosomiasis and {{w|soil-transmitted helminthiasis}} in eight countries over five years.<ref>{{cite web |title=Imperial initiative to protect children from tropical disease awarded £25m government backing |url=http://www.imperial.ac.uk/news/93621/imperial-initiative-protect-children-from-tropical/ |website=imperial.ac.uk |accessdate=11 March 2019}}</ref><ref name="Schistosomiasis Control Initiative: Supplementary Information"/> ||
 
|-
 
|-
 
| 2010 || || Statistics || The {{w|World Health Organization}} reports that schistosomiasis mortality could be as high as 280,000 per year in {{w|Africa}} alone.<ref name="Building a global schistosomiasis alliance: an opportunity to join forces to fight inequality and rural poverty"/> ||
 
| 2010 || || Statistics || The {{w|World Health Organization}} reports that schistosomiasis mortality could be as high as 280,000 per year in {{w|Africa}} alone.<ref name="Building a global schistosomiasis alliance: an opportunity to join forces to fight inequality and rural poverty"/> ||
 +
|-
 +
| 2011 || April || Review || GiveWell publishes review of SCI, describing it as a notable organization for its promising approach and for conducting evaluations of its activities, and considering as an "organization to watch."<ref>{{cite web |title=Schistosomiasis Control Initiative (SCI) - April 2011 Review |url=https://www.givewell.org/charities/Schistosomiasis-Control-Initiative/April-2011-review |website=givewell.org |accessdate=4 May 2019}}</ref> ||
 +
|-
 +
| 2011 || November || Review || GiveWell updates review of SCI and starts recommending the organization.<ref name="Update on the Schistosomiasis Control Initiative: Our current #2-ranked charity">{{cite web |title=Update on the Schistosomiasis Control Initiative: Our current #2-ranked charity |url=https://blog.givewell.org/2012/04/19/update-on-the-schistosomiasis-control-initiative-our-current-2-ranked-charity/ |website=blog.givewell.org |accessdate=4 May 2019}}</ref> This time, SCI is described as one of GiveWell's two top-rated charities.<ref>{{cite web |title=Schistosomiasis Control Initiative (SCI) - April 2011 Review |url=https://www.givewell.org/charities/Schistosomiasis-Control-Initiative/April-2011-review |website=givewell.org |accessdate=4 May 2019}}</ref> ||
 
|-
 
|-
 
| 2011 || || Expansion || SCI begins program in Liberia, Malawi, and Mozambique.<ref name="OUR REACH"/> || {{w|Liberia}}, {{w|Malawi}}, {{w|Mozanbique}}
 
| 2011 || || Expansion || SCI begins program in Liberia, Malawi, and Mozambique.<ref name="OUR REACH"/> || {{w|Liberia}}, {{w|Malawi}}, {{w|Mozanbique}}
Line 54: Line 60:
 
|-
 
|-
 
| 2012 || || Coverage || SCI reaches median coverage for schistosomiasis treatment at 77% in Malawi.<ref name="SCHISTOSOMIASIS CONTROL INITIATIVEd">{{cite web |title=SCHISTOSOMIASIS CONTROL INITIATIVE |url=https://www.givingwhatwecan.org/report/schistosomiasis-control-initiative/ |website=givingwhatwecan.org |accessdate=12 March 2019}}</ref> ||
 
| 2012 || || Coverage || SCI reaches median coverage for schistosomiasis treatment at 77% in Malawi.<ref name="SCHISTOSOMIASIS CONTROL INITIATIVEd">{{cite web |title=SCHISTOSOMIASIS CONTROL INITIATIVE |url=https://www.givingwhatwecan.org/report/schistosomiasis-control-initiative/ |website=givingwhatwecan.org |accessdate=12 March 2019}}</ref> ||
 +
|-
 +
| 2012 || November || Review || GiveWell updates review of SCI, and recommends the organization for its focus on a program with a strong track record and excellent cost-effectiveness, demonstrated results, and room for more funding.<ref name="Schistosomiasis Control Initiative - November 2011 Review">{{cite web |title=Schistosomiasis Control Initiative - November 2011 Review |url=https://www.givewell.org/charities/schistosomiasis-control-initiative/November-2011-review |website=givewell.org |accessdate=4 May 2019}}</ref> ||
 
|-
 
|-
 
| 2013 || April || Coverage || SCI announces that it has facilitated delivery of its 100 millionth treatment of {{w|praziquantel}} against schistosomiasis thanks to funding from private donations.<ref name="SCIvv"/> ||
 
| 2013 || April || Coverage || SCI announces that it has facilitated delivery of its 100 millionth treatment of {{w|praziquantel}} against schistosomiasis thanks to funding from private donations.<ref name="SCIvv"/> ||
Line 60: Line 68:
 
|-
 
|-
 
| 2013 || || || A reported 261 million people require preventive chemotherapy for schistosomiasis worldwide, 92% of them living in {{w|sub-Saharan Africa}} and only 12.7% receiving preventive chemotherapy.<ref name="Building a global schistosomiasis alliance: an opportunity to join forces to fight inequality and rural poverty">{{cite journal |last1=Savioli |first1=Lorenzo |last2=Albonico |first2=Marco |last3=Colley |first3=Daniel G. |last4=Correa-Oliveira |first4=Rodrigo |last5=Fenwick |first5=Alan |last6=Green |first6=Will |last7=Kabatereine |first7=Narcis |last8=Kabore |first8=Achille |last9=Katz |first9=Naftale |last10=Klohe |first10=Katharina |last11=LoVerde |first11=Philip T. |last12=Rollinson |first12=David |last13=Russell Stothard |first13=J. |last14=Tchuem Tchuenté |first14=Louis-Albert |last15=Waltz |first15=Johannes |last16=Zhou |first16=Xiao-Nong |title=Building a global schistosomiasis alliance: an opportunity to join forces to fight inequality and rural poverty |doi=10.1186/s40249-017-0280-8 |pmid=28330495 |url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363045/ |pmc=5363045}}</ref> ||
 
| 2013 || || || A reported 261 million people require preventive chemotherapy for schistosomiasis worldwide, 92% of them living in {{w|sub-Saharan Africa}} and only 12.7% receiving preventive chemotherapy.<ref name="Building a global schistosomiasis alliance: an opportunity to join forces to fight inequality and rural poverty">{{cite journal |last1=Savioli |first1=Lorenzo |last2=Albonico |first2=Marco |last3=Colley |first3=Daniel G. |last4=Correa-Oliveira |first4=Rodrigo |last5=Fenwick |first5=Alan |last6=Green |first6=Will |last7=Kabatereine |first7=Narcis |last8=Kabore |first8=Achille |last9=Katz |first9=Naftale |last10=Klohe |first10=Katharina |last11=LoVerde |first11=Philip T. |last12=Rollinson |first12=David |last13=Russell Stothard |first13=J. |last14=Tchuem Tchuenté |first14=Louis-Albert |last15=Waltz |first15=Johannes |last16=Zhou |first16=Xiao-Nong |title=Building a global schistosomiasis alliance: an opportunity to join forces to fight inequality and rural poverty |doi=10.1186/s40249-017-0280-8 |pmid=28330495 |url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363045/ |pmc=5363045}}</ref> ||
 +
|-
 +
| 2013 || November || Review || GiveWell updates review of SCI, maintaining its rating as a top-rated charity.<ref>{{cite web |title=Schistosomiasis Control Initiative (SCI) - 2013 Review |url=https://www.givewell.org/charities/schistosomiasis-control-initiative/November-2013-review |website=givewell.org |accessdate=4 May 2019}}</ref> ||
 
|-
 
|-
 
| 2013 – 2014 || Between November 2013 and April 2014 || || SCI funds mapping in {{w|Ethiopia}}.<ref name="Schistosomiasis Control Initiative: Supplementary Information"/> || {{w|Ethiopia}}
 
| 2013 – 2014 || Between November 2013 and April 2014 || || SCI funds mapping in {{w|Ethiopia}}.<ref name="Schistosomiasis Control Initiative: Supplementary Information"/> || {{w|Ethiopia}}
 +
|-
 +
| 2014 || June || Review || GiveWell updates review of SCI. It reports among notable plans a new opportunity to work with {{w|Sudan}} to create a national deworming program.<ref>{{cite web |title=Schistosomiasis Control Initiative - June 2014 Update |url=https://www.givewell.org/charities/schistosomiasis-control-initiative/June-2014#Spending_between_September_2013_and_March_2014 |website=givewell.org |accessdate=4 May 2019}}</ref> || {{w|Sudan}}
 
|-
 
|-
 
| 2014 || || Expansion || SCI begins program in the Democratic Republic of the Congo and Madagascar.<ref name="OUR REACH"/> || {{w|Democratic Republic of the Congo}}, {{w|Madagascar}}
 
| 2014 || || Expansion || SCI begins program in the Democratic Republic of the Congo and Madagascar.<ref name="OUR REACH"/> || {{w|Democratic Republic of the Congo}}, {{w|Madagascar}}
Line 69: Line 81:
 
| 2014 || || Funding || The British {{w|Department for International Development}} awards SCI an additional £16.6 million over four and a half years (June 2014 to December 2018) to extend the program and expand it to an additional two countries.<ref name="Schistosomiasis Control Initiative: Supplementary Information"/> ||
 
| 2014 || || Funding || The British {{w|Department for International Development}} awards SCI an additional £16.6 million over four and a half years (June 2014 to December 2018) to extend the program and expand it to an additional two countries.<ref name="Schistosomiasis Control Initiative: Supplementary Information"/> ||
 
|-
 
|-
| 2014 || || Coverage || ACI reaches median coverage for schistosomiasis treatment at 69% in Malawi, 82% in Côte d'Ivoire, and 47% in Uganda.<ref name="SCHISTOSOMIASIS CONTROL INITIATIVEd"/> ||
+
| 2014 || || Coverage || SCI reaches median coverage for schistosomiasis treatment at 69% in Malawi, 82% in Côte d'Ivoire, and 47% in Uganda.<ref name="SCHISTOSOMIASIS CONTROL INITIATIVEd"/> ||
 +
|-
 +
| 2014 || November || Review || GiveWell updates review of SCI, maintaining its rating as a top-rated charity.<ref>{{cite web |title=Schistosomiasis Control Initiative (SCI) - 2014 Review |url=https://www.givewell.org/charities/schistosomiasis-control-initiative/November-2014-review |website=givewell.org |accessdate=4 May 2019}}</ref> ||
 
|-
 
|-
 
| 2014 – 2015 || || Coverage || SCI reports having delivered 3.1 million treatments in Côte d'Ivoire in the period.<ref name="Schistosomiasis Control Initiative: Supplementary Information"/> || {{w|Côte d'Ivoire}}
 
| 2014 – 2015 || || Coverage || SCI reports having delivered 3.1 million treatments in Côte d'Ivoire in the period.<ref name="Schistosomiasis Control Initiative: Supplementary Information"/> || {{w|Côte d'Ivoire}}
Line 75: Line 89:
 
| 2015 || || Budget || SCI begins to use a system of country cashbooks for spending breakdown, which compare monthly in-country actual spending to budgets.<ref name="Schistosomiasis Control Initiative: Supplementary Information"/> ||
 
| 2015 || || Budget || SCI begins to use a system of country cashbooks for spending breakdown, which compare monthly in-country actual spending to budgets.<ref name="Schistosomiasis Control Initiative: Supplementary Information"/> ||
 
|-
 
|-
| 2015 || || Coverage || ACI reaches median coverage for schistosomiasis treatment at 81% in Mozambique, 93% in Zambia (2015), and 80% in Zanzibar.<ref name="SCHISTOSOMIASIS CONTROL INITIATIVEd"/> ||
+
| 2015 || || Coverage || SCI reaches median coverage for schistosomiasis treatment at 81% in Mozambique, 93% in Zambia (2015), and 80% in Zanzibar.<ref name="SCHISTOSOMIASIS CONTROL INITIATIVEd"/> ||
 
|-
 
|-
 
| 2015 || || || {{w|Schistosomiasis}} is indicated to have the lowest level of preventive chemotherapy implementation in the spectrum of neglected tropical diseases. It is also highlighted as the disease most lacking in progress.<ref name="Building a global schistosomiasis alliance: an opportunity to join forces to fight inequality and rural poverty"/> ||
 
| 2015 || || || {{w|Schistosomiasis}} is indicated to have the lowest level of preventive chemotherapy implementation in the spectrum of neglected tropical diseases. It is also highlighted as the disease most lacking in progress.<ref name="Building a global schistosomiasis alliance: an opportunity to join forces to fight inequality and rural poverty"/> ||
 +
|-
 +
| 2015 || August || Review || GiveWell updates review of SCI, and continues to recommend it for its track record implementing a cost-effective program.<ref>{{cite web |title=Schistosomiasis Control Initiative - August 2015 Update |url=https://www.givewell.org/charities/schistosomiasis-control-initiative/August-2015 |website=givewell.org |accessdate=4 May 2019}}</ref> ||
 +
|-
 +
| 2015 || November || Review || GiveWell updates review of SCI, maintaining its rating as a top-rated charity.<ref>{{cite web |title=Schistosomiasis Control Initiative (SCI) - 2015 Review |url=https://www.givewell.org/international/top-charities/schistosomiasis-control-initiative/2015-review#Is_there_room_for_more_funding |website=givewell.org |accessdate=4 May 2019}}</ref> ||
 
|-
 
|-
 
| 2015 – 2016 || || Program || SCI plans to deliver around 0.6 million treatments and reports delivering 1.4 million treatments in Côte d'Ivoire.<ref name="Schistosomiasis Control Initiative: Supplementary Information"/> ||
 
| 2015 – 2016 || || Program || SCI plans to deliver around 0.6 million treatments and reports delivering 1.4 million treatments in Côte d'Ivoire.<ref name="Schistosomiasis Control Initiative: Supplementary Information"/> ||
Line 88: Line 106:
 
|-
 
|-
 
| 2016 || January || Funding || {{w|Private foundation}} {{w|Good Ventures}} awards a grant of US$1,000,000 to the SCI for general operating support, in recognition of the organization’s earning a “top charity” ranking from {{w|GiveWell}} in 2015.<ref>{{cite web |title=Schistosomiasis Control Initiative — General Support (2016) |url=https://www.openphilanthropy.org/focus/global-health-and-development/miscellaneous/schistosomiasis-control-initiative-general-support-2016 |website=openphilanthropy.org |accessdate=11 March 2019}}</ref> ||
 
| 2016 || January || Funding || {{w|Private foundation}} {{w|Good Ventures}} awards a grant of US$1,000,000 to the SCI for general operating support, in recognition of the organization’s earning a “top charity” ranking from {{w|GiveWell}} in 2015.<ref>{{cite web |title=Schistosomiasis Control Initiative — General Support (2016) |url=https://www.openphilanthropy.org/focus/global-health-and-development/miscellaneous/schistosomiasis-control-initiative-general-support-2016 |website=openphilanthropy.org |accessdate=11 March 2019}}</ref> ||
 +
|-
 +
| 2016 || June || Review || GiveWell publishes review of SCI, retaining its role as top rated charity, but expressing concerns about SCI's use of an accounting system ill-suited to its needs, and substantial financial errors impacting funding from GiveWell-influenced donors.<ref>{{cite web |title=Schistosomiasis Control Initiative (SCI) – June 2016 version |url=https://www.givewell.org/charities/schistosomiasis-control-initiative/june-2016-version |website=givewell.org |accessdate=5 May 2019}}</ref> ||
 
|-
 
|-
 
| 2016 || August || Review || GiveWell estimates that programs supported by SCI can deworm a person for approximately US$1.26 based (including the estimated cost of SCI’s funding to country programs, SCI’s headquarters costs, cost of donated drugs, and local government involvement).<ref name="SCHISTOSOMIASIS CONTROL INITIATIVEd"/> ||
 
| 2016 || August || Review || GiveWell estimates that programs supported by SCI can deworm a person for approximately US$1.26 based (including the estimated cost of SCI’s funding to country programs, SCI’s headquarters costs, cost of donated drugs, and local government involvement).<ref name="SCHISTOSOMIASIS CONTROL INITIATIVEd"/> ||
 +
|-
 +
| 2016 || November || Review || {{w|GiveWell}} reviews SCI and ranks it as one of its top-rated charities, explaining that it "offers donors an outstanding opportunity to accomplish good with their donations".<ref>{{cite web |title=Schistosomiasis Control Initiative - January 2017 Version |url=https://www.givewell.org/charities/schistosomiasis-control-initiative/january-2017-version |website=givewell.org |accessdate=4 May 2019}}</ref> ||
 
|-
 
|-
 
| 2017 || January || Funding || Good Ventures awards a grant of US$13,500,000 to SCI for general operating support, in recognition of its earning a “top charity” ranking from GiveWell in 2016.<ref name="Schistosomiasis Control Initiative — General Support (2017)">{{cite web |title=Schistosomiasis Control Initiative — General Support (2017) |url=https://www.openphilanthropy.org/focus/global-health-and-development/miscellaneous/schistosomiasis-control-initiative-general-support-2017 |website=openphilanthropy.org |accessdate=11 March 2019}}</ref> ||
 
| 2017 || January || Funding || Good Ventures awards a grant of US$13,500,000 to SCI for general operating support, in recognition of its earning a “top charity” ranking from GiveWell in 2016.<ref name="Schistosomiasis Control Initiative — General Support (2017)">{{cite web |title=Schistosomiasis Control Initiative — General Support (2017) |url=https://www.openphilanthropy.org/focus/global-health-and-development/miscellaneous/schistosomiasis-control-initiative-general-support-2017 |website=openphilanthropy.org |accessdate=11 March 2019}}</ref> ||
 
|-
 
|-
 
| 2017 || October || Budget || SCI estimates that it would cost US$0.24 on average per additional treatment delivered to a school-aged child.<ref name="Schistosomiasis Control Initiative: Supplementary Information"/> ||
 
| 2017 || October || Budget || SCI estimates that it would cost US$0.24 on average per additional treatment delivered to a school-aged child.<ref name="Schistosomiasis Control Initiative: Supplementary Information"/> ||
 +
|-
 +
| 2017 || November || Review || GiveWell updates review on SCI and estimates that it could productively use roughly US$30 million more than it expects to receive to deliver treatments to school-aged children over the next three years. It could use almost three times this amount if it were to follow {{w|World Health Organization}} guidelines, which recommend treating adults in certain circumstances. However, GiveWell does not recommend funding to treat adults because it has not seen sufficient evidence on the impact of treating adults.<ref>{{cite web |title=Schistosomiasis Control Initiative - November 2017 Version |url=https://www.givewell.org/charities/schistosomiasis-control-initiative/November-2017-version |website=givewell.org |accessdate=4 May 2019}}</ref> ||
 
|-
 
|-
 
| 2017 || || Budget || GiveWell allocates 100% of its discretionary fund to the SCI in the fourth quarter of the year, totalling US$5.6 million.<ref name="HOW YOUR MONEY IS SPENT">{{cite web |title=HOW YOUR MONEY IS SPENT |url=https://www.schistosomiasiscontrolinitiative.org/how-money-is-spent |website=schistosomiasiscontrolinitiative.org |accessdate=15 March 2019}}</ref> ||  
 
| 2017 || || Budget || GiveWell allocates 100% of its discretionary fund to the SCI in the fourth quarter of the year, totalling US$5.6 million.<ref name="HOW YOUR MONEY IS SPENT">{{cite web |title=HOW YOUR MONEY IS SPENT |url=https://www.schistosomiasiscontrolinitiative.org/how-money-is-spent |website=schistosomiasiscontrolinitiative.org |accessdate=15 March 2019}}</ref> ||  
 
|-
 
|-
| 2018 || || || GiveWell allocates 100% of its discretionary fund to the SCI, totalling US$5.6 million. It allocates a further $0.89 million to the SCI in the first quarter of 2018, which is 30% of its discretionary fund for that period.<ref name="HOW YOUR MONEY IS SPENT"/> ||
+
| 2018 || March || Funding || GiveWell allocates 100% of its discretionary fund to SCI, totalling US$5.6 million. It allocates a further $0.89 million to the SCI in the first quarter of 2018, which is 30% of its discretionary fund for that period.<ref name="HOW YOUR MONEY IS SPENT"/><ref name="Discretionary Grantmaking"/> ||
 +
|-
 +
| 2018 || May || Funding || GiveWell allocates 30% of its US$3 million in discretionary fund to SCI.<ref name="Discretionary Grantmaking"/> ||
 +
|-
 +
| 2018 || August || Funding || GiveWell allocates 30% of its US$4.1 million in discretionary fund to SCI.<ref name="Discretionary Grantmaking">{{cite web |title=Discretionary Grantmaking |url=https://www.givewell.org/about/FAQ/discretionary-grantmaking |website=givewell.org |accessdate=19 April 2019}}</ref> ||
 +
|-
 +
| 2018 || November || Funding || GiveWell recommends that {{w|Good Ventures}} grant $2.5 million to SCI,<ref>{{cite web |title=2018 Allocation to GiveWell Top Charities |url=https://www.openphilanthropy.org/blog/2018-allocation-givewell-top-charities |website=openphilanthropy.org |accessdate=20 April 2019}}</ref> which is recommended for its focus on a program with a strong track record and excellent cost-effectiveness, standout transparency, and room for more funding.<ref>{{cite web |title=Schistosomiasis Control Initiative |url=https://www.givewell.org/charities/Schistosomiasis-Control-Initiative |website=givewell.org |accessdate=4 May 2019}}</ref> ||
 
|-
 
|-
 
| 2019 || March || Funding || {{w|GiveWell}} updates its estimate of SCI's room for more funding from US$16.8 million to $28.7 million as a result of incorporating SCI's updates to its projections for how much funding it expects to receive from other funders over the next few years.<ref name="Schistosomiasis Control Initiative: Supplementary Information"/> ||
 
| 2019 || March || Funding || {{w|GiveWell}} updates its estimate of SCI's room for more funding from US$16.8 million to $28.7 million as a result of incorporating SCI's updates to its projections for how much funding it expects to receive from other funders over the next few years.<ref name="Schistosomiasis Control Initiative: Supplementary Information"/> ||
Line 122: Line 152:
  
 
==See also==
 
==See also==
 +
 +
* [[Timeline of deworming]]
 +
* [[Timeline of GiveWell]]
 +
* [[Timeline of Against Malaria Foundation]]
  
 
==External links==
 
==External links==

Latest revision as of 12:39, 21 May 2019

This is a timeline of Schistosomiasis Control Initiative, a non-profit initiative that works with governments in sub-Saharan African countries to create or scale up programs that treat schistosomiasis and soil-transmitted helminthiasis.[1]

Big picture

Time period Development summary
2006 SCI becomes a founding partner of the Global Network for Neglected Tropical Diseases which promotes integration of control or elimination programmes against seven neglected tropical diseases.
2007 SCI facilitates delivery of approximately 40 million treatments of praziquantel against schistosomiasis, and many more deworming doses of albendazole.[2]
2010 SCI expands its reach after the award of the management of ICOSA, a programme funded by the Department for International Development (DFID).[2]
2013 SCI announces that it has facilitated delivery of its 100 millionth treatment of praziquantel against schistosomiasis thanks to funding from private donations.[2]
2016 SCI reaches an annual delivery of over 50 million treatments for schistosomiasis and soil-transmitted helminths.[2]
2018 SCI facilitates the delivery of its 200 millionth treatment against parasitic worm infections.[2]

Full timeline

Year Month and date Event type Details Location
2002 SCI is founded through a US$32 million grant from the Bill and Melinda Gates Foundation[1], to tackle schistosomiasis in sub-Saharan Africa, where infected people are unable to afford the drugs needed for treatment.[3][4]
2002 Expansion SCI begins program in Uganda, the first operating country.[5] Uganda
2003 October Program SCI selects six countries for full support: Uganda, Burkina Faso, Niger, Mali, Tanzania, and Zambia. The countries each propose a different implementation approach and management structure for their large-scale schistosomiasis control.[6]
2003 Expansion SCI begins program in Zambia, Zanzibar, and Niger.[5][7][8][9] Zambia, Zanzibar, Niger
2006 Funding SCI receives large grants from the United States Agency for International Development and the Bill & Melinda Gates Foundation to support integrated NTD programs in eight countries for five years to treat lymphatic filariasis, onchocerciasis, and trachoma, in addition to schistosomiasis and soil-transmitted helminths.[1]
2007 Funding SCI receives a grant to expand its work to Rwanda and Burundi.[1]
2007 Expansion SCI program starts in Burundi.[5] Burundi
2008 Organization The Schistosomiasis Consortium for Operational Research and Evaluation (SCORE) is established to answer strategic questions about schistosomiasis control.[10]
2009 Review GiveWell begins reviewing SCI.[11]
2010 Expansion SCI begins working in Côte d'Ivoire.[1] Côte d'Ivoire
2010 October Funding SCI receives £10.5 million (plus separate funding for drugs) from the British Department for International Development for treating schistosomiasis and soil-transmitted helminthiasis in eight countries over five years.[12][1]
2010 Statistics The World Health Organization reports that schistosomiasis mortality could be as high as 280,000 per year in Africa alone.[13]
2011 April Review GiveWell publishes review of SCI, describing it as a notable organization for its promising approach and for conducting evaluations of its activities, and considering as an "organization to watch."[14]
2011 November Review GiveWell updates review of SCI and starts recommending the organization.[15] This time, SCI is described as one of GiveWell's two top-rated charities.[16]
2011 Expansion SCI begins program in Liberia, Malawi, and Mozambique.[5] Liberia, Malawi, Mozanbique
2012 Expansion SCI program starts in Côte d'Ivoire, two years later due to political turmoil.[1][5] Côte d'Ivoire
2012 Expansion SCI begins conversations with the Government of Ethiopia about starting a national schistosomiasis treatment program.[1] Ethiopia
2012 Coverage SCI reaches median coverage for schistosomiasis treatment at 77% in Malawi.[17]
2012 November Review GiveWell updates review of SCI, and recommends the organization for its focus on a program with a strong track record and excellent cost-effectiveness, demonstrated results, and room for more funding.[11]
2013 April Coverage SCI announces that it has facilitated delivery of its 100 millionth treatment of praziquantel against schistosomiasis thanks to funding from private donations.[2]
2013 Expansion SCI begins first round of treatment in Ethiopia and Mauritania.[1][5][1][5] Ethiopia, Mauritania
2013 A reported 261 million people require preventive chemotherapy for schistosomiasis worldwide, 92% of them living in sub-Saharan Africa and only 12.7% receiving preventive chemotherapy.[13]
2013 November Review GiveWell updates review of SCI, maintaining its rating as a top-rated charity.[18]
2013 – 2014 Between November 2013 and April 2014 SCI funds mapping in Ethiopia.[1] Ethiopia
2014 June Review GiveWell updates review of SCI. It reports among notable plans a new opportunity to work with Sudan to create a national deworming program.[19] Sudan
2014 Expansion SCI begins program in the Democratic Republic of the Congo and Madagascar.[5] Democratic Republic of the Congo, Madagascar
2014 Collaboration SCI begins working with other partners in Côte d'Ivoire, including Sightsavers, the END Fund, and Helen Keller International on a more integrated neglected tropical diseases (NTD) program.[1]
2014 Funding The British Department for International Development awards SCI an additional £16.6 million over four and a half years (June 2014 to December 2018) to extend the program and expand it to an additional two countries.[1]
2014 Coverage SCI reaches median coverage for schistosomiasis treatment at 69% in Malawi, 82% in Côte d'Ivoire, and 47% in Uganda.[17]
2014 November Review GiveWell updates review of SCI, maintaining its rating as a top-rated charity.[20]
2014 – 2015 Coverage SCI reports having delivered 3.1 million treatments in Côte d'Ivoire in the period.[1] Côte d'Ivoire
2015 Budget SCI begins to use a system of country cashbooks for spending breakdown, which compare monthly in-country actual spending to budgets.[1]
2015 Coverage SCI reaches median coverage for schistosomiasis treatment at 81% in Mozambique, 93% in Zambia (2015), and 80% in Zanzibar.[17]
2015 Schistosomiasis is indicated to have the lowest level of preventive chemotherapy implementation in the spectrum of neglected tropical diseases. It is also highlighted as the disease most lacking in progress.[13]
2015 August Review GiveWell updates review of SCI, and continues to recommend it for its track record implementing a cost-effective program.[21]
2015 November Review GiveWell updates review of SCI, maintaining its rating as a top-rated charity.[22]
2015 – 2016 Program SCI plans to deliver around 0.6 million treatments and reports delivering 1.4 million treatments in Côte d'Ivoire.[1]
2015 – 2016 Between April 2015 and March 2016 SCI spends around US$2.1 million in unrestricted funding and $0.8 million in restricted funding in Ethiopia during the period.[1] Ethiopia
2015 – 2016 Between April 2015 and March 2016 Coverage SCI reports having delivered 890,000 treatments in Uganda, out of 1.2 million planned treatments.[1]
2016 Expansion SCI begins program in Nigeria.[5] Nigeria
2016 January Funding Private foundation Good Ventures awards a grant of US$1,000,000 to the SCI for general operating support, in recognition of the organization’s earning a “top charity” ranking from GiveWell in 2015.[23]
2016 June Review GiveWell publishes review of SCI, retaining its role as top rated charity, but expressing concerns about SCI's use of an accounting system ill-suited to its needs, and substantial financial errors impacting funding from GiveWell-influenced donors.[24]
2016 August Review GiveWell estimates that programs supported by SCI can deworm a person for approximately US$1.26 based (including the estimated cost of SCI’s funding to country programs, SCI’s headquarters costs, cost of donated drugs, and local government involvement).[17]
2016 November Review GiveWell reviews SCI and ranks it as one of its top-rated charities, explaining that it "offers donors an outstanding opportunity to accomplish good with their donations".[25]
2017 January Funding Good Ventures awards a grant of US$13,500,000 to SCI for general operating support, in recognition of its earning a “top charity” ranking from GiveWell in 2016.[26]
2017 October Budget SCI estimates that it would cost US$0.24 on average per additional treatment delivered to a school-aged child.[1]
2017 November Review GiveWell updates review on SCI and estimates that it could productively use roughly US$30 million more than it expects to receive to deliver treatments to school-aged children over the next three years. It could use almost three times this amount if it were to follow World Health Organization guidelines, which recommend treating adults in certain circumstances. However, GiveWell does not recommend funding to treat adults because it has not seen sufficient evidence on the impact of treating adults.[27]
2017 Budget GiveWell allocates 100% of its discretionary fund to the SCI in the fourth quarter of the year, totalling US$5.6 million.[28]
2018 March Funding GiveWell allocates 100% of its discretionary fund to SCI, totalling US$5.6 million. It allocates a further $0.89 million to the SCI in the first quarter of 2018, which is 30% of its discretionary fund for that period.[28][29]
2018 May Funding GiveWell allocates 30% of its US$3 million in discretionary fund to SCI.[29]
2018 August Funding GiveWell allocates 30% of its US$4.1 million in discretionary fund to SCI.[29]
2018 November Funding GiveWell recommends that Good Ventures grant $2.5 million to SCI,[30] which is recommended for its focus on a program with a strong track record and excellent cost-effectiveness, standout transparency, and room for more funding.[31]
2019 March Funding GiveWell updates its estimate of SCI's room for more funding from US$16.8 million to $28.7 million as a result of incorporating SCI's updates to its projections for how much funding it expects to receive from other funders over the next few years.[1]

Meta information on the timeline

How the timeline was built

The initial version of the timeline was written by User:Sebastian.

Funding information for this timeline is available.

Feedback and comments

Feedback for the timeline can be provided at the following places:

  • FIXME

What the timeline is still missing

Timeline update strategy

See also

External links

References

  1. 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 1.11 1.12 1.13 1.14 1.15 1.16 1.17 1.18 1.19 "Schistosomiasis Control Initiative: Supplementary Information". givewell.org. Retrieved 11 March 2019. 
  2. 2.0 2.1 2.2 2.3 2.4 2.5 "SCI". schistosomiasiscontrolinitiative.org. Retrieved 10 April 2019. 
  3. "Ten million Africans treated by international disease treatment programme". imperial.ac.uk. Retrieved 12 March 2019. 
  4. Adenowoa, Abiola Fatimah; Oyinloyea, Babatunji Emmanuel; Ogunyinkaa, Bolajoko Idiat; Kappo, Abidemi Paul. "Impact of human schistosomiasis in sub-Saharan Africa". Brazilian Journal of Infectious Diseases. doi:10.1016/j.bjid.2014.11.004. 
  5. 5.0 5.1 5.2 5.3 5.4 5.5 5.6 5.7 5.8 "OUR REACH". schistosomiasiscontrolinitiative.org. Retrieved 12 March 2019. 
  6. "Schistosomiasis Control Initiative (SCI) — 2015 Review, Updated April 2016". givewell.org. Retrieved 12 March 2019. 
  7. "ZAMBIA". schistosomiasiscontrolinitiative.org. Retrieved 10 April 2019. 
  8. "ZANZIBAR". schistosomiasiscontrolinitiative.org. Retrieved 10 April 2019. 
  9. "NIGER". schistosomiasiscontrolinitiative.org. Retrieved 10 April 2019. 
  10. Ezeamama, Amara E.; He, Chun-La; Shen, Ye; Yin, Xiao-Ping; Binder, Sue C.; CampbellJr., Carl H.; Rathbun, Stephen; Whalen, Christopher C.; N’Goran, Eliézer K.; Utzinger, Jürg; Olsen, Annette; Magnussen, Pascal; Kinung’hi, Safari; Fenwick, Alan; Phillips, Anna; Ferro, Josefo; Karanja, Diana M. S.; Mwinzi, Pauline N. M.; Montgomery, Susan; Secor, W. Evan; Hamidou, Amina; Garba, Amadou; King, Charles H.; Colley, Daniel G. "Gaining and sustaining schistosomiasis control: study protocol and baseline data prior to different treatment strategies in five African countries". doi:10.1186/s12879-016-1575-2. 
  11. 11.0 11.1 "Schistosomiasis Control Initiative - November 2011 Review". givewell.org. Retrieved 4 May 2019. 
  12. "Imperial initiative to protect children from tropical disease awarded £25m government backing". imperial.ac.uk. Retrieved 11 March 2019. 
  13. 13.0 13.1 13.2 Savioli, Lorenzo; Albonico, Marco; Colley, Daniel G.; Correa-Oliveira, Rodrigo; Fenwick, Alan; Green, Will; Kabatereine, Narcis; Kabore, Achille; Katz, Naftale; Klohe, Katharina; LoVerde, Philip T.; Rollinson, David; Russell Stothard, J.; Tchuem Tchuenté, Louis-Albert; Waltz, Johannes; Zhou, Xiao-Nong. "Building a global schistosomiasis alliance: an opportunity to join forces to fight inequality and rural poverty". PMC 5363045Freely accessible. PMID 28330495. doi:10.1186/s40249-017-0280-8. 
  14. "Schistosomiasis Control Initiative (SCI) - April 2011 Review". givewell.org. Retrieved 4 May 2019. 
  15. "Update on the Schistosomiasis Control Initiative: Our current #2-ranked charity". blog.givewell.org. Retrieved 4 May 2019. 
  16. "Schistosomiasis Control Initiative (SCI) - April 2011 Review". givewell.org. Retrieved 4 May 2019. 
  17. 17.0 17.1 17.2 17.3 "SCHISTOSOMIASIS CONTROL INITIATIVE". givingwhatwecan.org. Retrieved 12 March 2019. 
  18. "Schistosomiasis Control Initiative (SCI) - 2013 Review". givewell.org. Retrieved 4 May 2019. 
  19. "Schistosomiasis Control Initiative - June 2014 Update". givewell.org. Retrieved 4 May 2019. 
  20. "Schistosomiasis Control Initiative (SCI) - 2014 Review". givewell.org. Retrieved 4 May 2019. 
  21. "Schistosomiasis Control Initiative - August 2015 Update". givewell.org. Retrieved 4 May 2019. 
  22. "Schistosomiasis Control Initiative (SCI) - 2015 Review". givewell.org. Retrieved 4 May 2019. 
  23. "Schistosomiasis Control Initiative — General Support (2016)". openphilanthropy.org. Retrieved 11 March 2019. 
  24. "Schistosomiasis Control Initiative (SCI) – June 2016 version". givewell.org. Retrieved 5 May 2019. 
  25. "Schistosomiasis Control Initiative - January 2017 Version". givewell.org. Retrieved 4 May 2019. 
  26. "Schistosomiasis Control Initiative — General Support (2017)". openphilanthropy.org. Retrieved 11 March 2019. 
  27. "Schistosomiasis Control Initiative - November 2017 Version". givewell.org. Retrieved 4 May 2019. 
  28. 28.0 28.1 "HOW YOUR MONEY IS SPENT". schistosomiasiscontrolinitiative.org. Retrieved 15 March 2019. 
  29. 29.0 29.1 29.2 "Discretionary Grantmaking". givewell.org. Retrieved 19 April 2019. 
  30. "2018 Allocation to GiveWell Top Charities". openphilanthropy.org. Retrieved 20 April 2019. 
  31. "Schistosomiasis Control Initiative". givewell.org. Retrieved 4 May 2019.